Duearity AB (publ) (DEAR.ST) Research

Established in Malmö, Sweden, in 2020, Duearity AB (publ) operates in the medical technology sector, specializing in treatments for tinnitus. Their flagship product, Tinearity, is an innovative aid that utilizes a compact sound emitter to produce therapeutic white noise, delivered directly into the user's ear through bone conduction via the skull. Additionally, the company is actively developing Tinearity AI, an artificial intelligence-powered solution intended to empower those affected by tinnitus to effectively control their symptoms.

Market snapshot

Symbol
DEAR.ST
Price
$0.02
Day change
0.00%
Market cap
$3.1M
P/E ratio
-0.01x
52-week range
0.0135-2.29
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Asarina Pharma AB (publ) (ASAP.ST)
  • Bioservo Technologies AB (publ) (BIOS.ST)
  • Bonzun AB (publ) (BONZUN.ST)
  • Cline Scientific AB (publ) (CLINE-B.ST)
  • Cyxone AB (publ) (CYXO.ST)
  • Hemcheck Sweden AB (publ) (HEMC.ST)
  • Pharmacolog i Uppsala AB (publ) (PHLOG-B.ST)
  • Redwood Pharma AB (REDW.ST)

Open Duearity AB (publ) (DEAR.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.